A newly developed therapy inspired by bacteria residing within tumors offers a different way to combat cancer by targeting ...
Breakthrough in resistance: Mount Sinai scientists discovered a method to restore immune cell communication, tackling colorectal cancer's resistance to current immunotherapies. Combination therapy ...
MUSC researchers are tackling MASH, or metabolic dysfunction-associated steatohepatitis, a liver disease affecting hundreds ...
Plant scientist Dario Leister and his team are investigating how cyanobacteria adapt to rapidly changing light intensities.
Every drug approved for Parkinson’s disease does the same thing: it manages symptoms. None slows the underlying destruction ...
Subscribe to The Post Most newsletter for the most important and interesting stories from. They arrive in cheerful bottles ...
Researchers at the Icahn School of Medicine at Mount Sinai and the Mount Sinai Tisch Cancer Center have identified a ...
When this is done well, biomarkers accelerate decision-making, reduce uncertainty, and ultimately bring improved therapies to patients faster. When this is done poorly, however, biomarkers can add ...
37604, May 06, 2026 (GLOBE NEWSWIRE) -- JOHNSON CITY, Tenn. – Ballad Health welcomed a record second class of 207 students to its Ballad Health Academy program with a series of events hosted at area ...
Beginning in Fall 2026, Jefferson College of Nursing will broaden its footprint by offering onsite nursing education at the ...
Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer, ...
Rejuvenation is one of the newest and most promising developments in longevity research, a field that began in earnest in ...